Annual Report & AGM Notice

2013 Annual Report and AGM Notice

London, 15 October 2013 - Sinclair IS Pharma plc (AIM:SPH.L) ("the Company"), the international specialty pharmaceutical company, announces that it has posted to shareholders its Annual Report and Accounts for the year ended 30 June 2013 together with notice of the Company's annual general meeting to be held on 6 November 2013.

These documents are now available on the company's website at www.sinclairispharma.com.

Ends

Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner 

Alan Olby

Robert Taylor

Peel Hunt LLP Tel: +44 (0) 20 7418 8900

James Steel

Vijay Barathan

Notes to Editors:

About Sinclair IS Pharma plc - see www.sinclairispharma.com

Sinclair IS Pharma is an international specialty pharmaceutical company centred on Dermatology, in particular - Aesthetics, Wound care, and Skin care. The Group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners.

"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward‐looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward‐looking statements due to a variety of factors.